Yiqiao Shenzhou launches full-length p-Tau217 protein to support the development of biomarkers for Alzheimer's disease detection.

According to Yiqiao Shenzhou, the company officially announced the launch of the recombinant human p-Tau217 protein. This product is a full-length, tag-free Tau protein reagent. With its full-length sequence, tag-free molecular conformation, and clear phosphorylation modification characteristics, the p-Tau217 protein can support the development of Alzheimer's disease biomarker detection in plasma and cerebrospinal fluid pathways. It can also be used in various scenarios such as antibody screening and specificity validation, development of detection quality control products, and research on Tau protein phosphorylation mechanisms.